Ignite Creation Date:
2024-05-06 @ 3:03 PM
Last Modification Date:
2024-10-26 @ 1:42 PM
Study NCT ID:
NCT04508842
Status:
TERMINATED
Last Update Posted:
2022-09-28
First Post:
2020-08-09
Brief Title:
CD19CD22-Dual-STAR-T for Patients With B Cell Acute LeukemiaB-ALL
Sponsor:
Hebei Yanda Ludaopei Hospital
Organization:
Hebei Yanda Ludaopei Hospital
Organization Data
Organization:
Hebei Yanda Ludaopei Hospital
Class:
OTHER
Study ID:
HXYT-011
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Hebei Yanda Ludaopei Hospital
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| China Immunotech Beijing Biotechnology Co Ltd | INDUSTRY |